Total preliminary 4Q and full year 2025 net product revenue of $196.0 million and $638.5 million, respectively, representing 65% and 66% annual ...

44 th Annual J.P. Morgan Healthcare Conference Format: Company presentation Date: Thursday, January 15, 2026 Time: 12:00 PM PT Location: California East at The Westin St. Francis ...

AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the ...

A biopharmaceuticals company has announced a $200 million expansion in Fishers, with the expectation that in five years the ...

Day One Biopharmaceuticals’ latest update left its fair value estimate unchanged at $22.25 per share, even as the discount rate edged slightly higher to about 7.02%, reflecting a marginally higher ...

The global burden of cancer, autoimmune disorders, metabolic diseases, and rare genetic conditions continues to increase. As traditional therapies show limitations in managing these conditions, the ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

(RTTNews) - Mersana Therapeutics, Inc. (MRSN), a biopharmaceutical company, Thursday, announced that it has entered a definitive agreement to be acquired by Day One Biopharmaceuticals through a tender ...

The deal value comprises an upfront consideration of $25.00 per share in cash plus up to an aggregate of $30.25 per share in cash potentially payable under contingent value rights, representing a ...

CAMBRIDGE, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) ...

The Global Bio Pharmaceuticals Market is valued at USD 421.58 Billion in 2024 and is projected to attain a value of USD 1555 Billion by 2035 at a CAGR of 12.65% during the forecast period 2025-2035, ...